Table 1.

Demographic and Socioeconomic Characteristics of Individuals Reporting Psychotherapy Visit, Psychiatry Visit, and Antidepressant/Antipsychotic Medication

Whole Population (n = 90,853)Psychotherapy Visit (n = 4,503)Psychiatry Visit (n = 3,279)Antidepressant/Antipsychotic (n = 9,859)
% of population (95% CI)5.2 (4.9–5.4)3.6 (3.4–3.8)11.2 (10.8–5.4)
Age (Median [IQR])38 [19, 58]34 [20, 51]39 [23, 57]53 [37, 66]
Sex (% female, 95% CI)51.0 (50.6–51.4)60.1 (58.5–61.8)57.1 (55.1–59.1)68.3 (67.1–69.5)
Health insurance (%, 95% CI)
 Any private67.4 (66.2–68.7)67.7 (65.1–70.2)59.9 (56.8–62.9)64.4 (62.6–66.1)
 Only public26.1 (25.1–27.2)30.1 (27.6–32.7)37.7 (34.9–40.7)33.3 (31.7–35.0)
 No insurance6.5 (6.1–6.9)2.2 (1.7–2.8)2.3 (1.7–3.2)2.3 (1.9–2.8)
Race/ethnicity (%, 95% CI)
 White (non-Hispanic)59.8 (58.1–61.4)71.8 (69.7–73.9)68.2 (65.7–70.8)80.2 (78.9–81.5)
 Black (non-Hispanic)12.3 (11.4–13.3)9.1 (7.7–10.6)11.1 (9.6–12.8)6.2 (5.5–7.1)
 Hispanic18.4 (17.0–19.9)11.6 (10.3–13.2)13.4 (11.7–15.2)8.4 (7.5–9.4)
 Asian (non-Hispanic)6.1 (5.5–6.8)2.2 (1.7-3.0)2.7 (2.0–3.5)1.7 (1.4-2.2)
 Other3.4 (3.1–3.7)5.2 (4.4–6.2)4.5 (3.6–5.6)3.4 (2.9–4.0)
Region (%, 95% CI)
 Northeast17.2 (15.2–19.4)21.9 (18.9–25.4)21.5 (18.3–25.2)17.2 (14.7–20.0)
 Midwest20.9 (19.3–22.6)24.8 (22.1–27.8)21.5 (19.0–24.2)25.3 (23.0–27.7)
 South38.0 (35.5–40.5)28.0 (25.0–31.2)36.6 (33.0–40.3)37.6 (34.9–40.5)
 West23.9 (21.8–26.2)25.2 (22.3–28.3)20.4 (17.3–23.8)19.8 (17.4–22.5)
Any psychotherapy visits5.2 (4.9–5.4)40.8 (38.3–43.3)20.7 (19.5–21.8)
 Psychotherapy visits (Median [IQR])0 [0, 0]6 [2, 16]0 [0, 5]0 [0, 0]
Any psychiatry visits3.6 (3.4–3.8)28.2 (26.3–30.2)21.2 (20.0–22.5)
 Psychiatry visits (Median [IQR])0 [0, 0]0 [0, 1]3 [1, 5]0 [0, 0]
Antidepressant/antipsychotic medication11.2 (10.8–11.6)44.6 (42.4–46.9)66.0 (63.7–68.3)
  • Abbreviation: IQR, interquartile range; CI, confidence interval.